Senate
93rd General Assembly (2021 Regular)
Passed
SB639
To Authorize Off-label Use Of Drug Treatments To Treat Patients Diagnosed With Pediatric Acute-onset Neuropsychiatric Syndrome And Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infection.
To Authorize Off-label Use Of Drug Treatments To Treat Patients Diagnosed With Pediatric Acute-onset Neuropsychiatric Syndrome And Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infection.
Bill Summary
To Authorize Off-label Use Of Drug Treatments To Treat Patients Diagnosed With Pediatric Acute-onset Neuropsychiatric Syndrome And Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infection.
Influence Proximity
1st Degree Direct
2nd Degree Shared
3rd Degree Extended
Network Filters
Last Updated
Passed
Apr 30, 2021
Apr 30, 2021